🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A 26 week trial of TransCon hGH, a long-acting growth hormone product, admi...
Status
Completed
Location
University of Alabama
Start Date
2017-11-13
Trial ID
NCT03305016
Treatments Being Tested
A multicenter, phase 3, long-term extension trial of TransCon hGH administe...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2017-12-19
Trial ID
NCT03344458
Treatments Being Tested
A 52 week trial of TransCon hGH, a long-acting growth hormone product, vers...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2016-12-13
Trial ID
NCT02781727
This was a phase 3 open-label multicenter extension study designed to evalu...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2021-12-16
Trial ID
NCT05171855
Treatments Being Tested
This study investigates the safety, tolerability, pharmacokinetic profile (...
Status
Completed
Location
Aarhus University Hospital
Start Date
2010-11
Trial ID
NCT01247675
Treatments Being Tested
A 38-week dosing trial of lonapegsomatropin, a long-acting growth hormone p...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2020-12-03
Trial ID
NCT04615273
Treatments Being Tested
This study is conducted in China only. The purpose is to demonstrate the ef...
Status
Unknown
Location
Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Start Date
2019-12-30
Trial ID
NCT04326374
Treatments Being Tested
The goal of this study is to further characterise the potential long-term s...
Status
Recruiting
Location
Ascendis Investigational Site
Start Date
2023-03-20
Trial ID
NCT05775523
Treatments Being Tested